Redeye has updated its estimates following Heliospectra’s Q4 2025 report. While 2025 was a financially demanding year defined by restructuring and weak markets, the company enters 2026 with a reinforced balance sheet and a more mature organisation. Backed by successful recent trials and an expanding shortlist of large-scale greenhouse projects, Heliospectra is now strategically positioned to capture the anticipated market rebound in 2026.
LÄS MER
